Activating Compound | Comment | Organism | Structure |
---|---|---|---|
Colchicine | 450 microM, 50% stimulation | Homo sapiens | |
rhodamine B | 44 microM, 50% stimulation | Homo sapiens | |
verapamil | 12 microM, 50% stimulation | Homo sapiens | |
vinblastine | 2.2 microM, 50% stimulation | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
L175C/N820C | introduction of cysteine residues into regions of TM3, residues 175-178, and TM9, residues 820822. Treatment with 1,1-methanediyl bismethanethiosulfonate results in cross-linking of the majority of protein. Cross-linking is not increased in the presence of ATP or drug substrates. Cross-linking increases the mutant's basal ATPase activity about 3fold. Activity can be increased further by drug substrates such as verapamil and rhodamine B | Homo sapiens |
additional information | introduction of cysteine residues into regions of TM3, residues 175-178, and TM9, residues 820822, that extend into the cytoplasm and are 4 A and 20 A apart in the closed and open conformations, respectively. Cross-linking of the double mutants with a short cross-linker, 1,1-methanediyl bismethanethiosulfonate at 0°C results only in cross-linking of mutant L175C/N820C | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
General Information | Comment | Organism |
---|---|---|
physiological function | P-gp in the membrane is in the closed conformation that has a high affinity for drug substrates | Homo sapiens |